Number Cruncher Extra

Number Cruncher Extra – Empire Company Ltd., Quebecor Inc. & Atco Ltd.

By August 30, 2022 No Comments

in our last Number Cruncher we discussed how Empire Company Ltd. (EMP.A), Quebecor Inc. (QBR.B) & Atco Ltd (ACO.X) are profitable companies trading at a reasonable price.

Here is the screener we used to find these stocks and that you can add to your personalized screeners.

Let’s start with EMP.A

The company has a healthy SP score of 76, and increased by a massive 10 points in the last 90 days. The SP score is derived from the high performance (76.5) and risk score (23.5) . The company has a moderate exposure to all factor ranging from 58 for yield to 74 for quality. Sales increased by 6.7% year-over-year and increased by an annualized 5.7 per cent over 5 years. Moreover, earnings per share increased by 7.6% in the last year and by a robust 55.4% per year in the last 5 years.

We see that the company has the best best exposure to factors compared to peers and shine in the value and yield factors compared to peers.

Let’s continue with QBR.B

The company has a score of 74 which was unchanged in the last 90 days. The SP score is derived from the performance (75.5) and risk (25.7) score. The company has a respectable quality exposure of 73. The company reported vigorous year-over-year earnings growth of 16% with a robust  5-year annualized EPS growth of 18.7%.

 

5 years ago, our system evaluated the company to be fairly priced, but in the past 2 years, there is a clear divergence between our valuation and the share price and it is growing year after year. It could be interesting to dig a bit deeper to determine if that valuation gap could potentially close.

Finally, ACO.X

ACO.X has a SP score of 65 with a 4 point increase in the last 90 days. The SP score is derived from the performance (64.4) and risk (29.8) score. The company has a sizeable low volatility exposure with a score of 77 and respectable momentum exposure at 72. The company achieved volatile sales and earnings in the last 5 years which resulted in no sales growth over those years which could explain its growth factor exposure of only 29.

ACO.X didn’t increase it’s NOPAT or EVA in the last years, but these metrics have an interesting short term trend that we certainly need to keep an eye on.

 

If you have any questions about the article, feel free to contact Anthony :
Amenard@Inovestor.com

If you would like to sign up for a free trial and learn how Inovestor can benefit you, contact Olivier:
Olamothe@Inovestor.com